Table with 4 columns and 4 rows. Currently displaying rows 1 to 4.
Moderna’s mRNA-1010Seasonal influenzaPhase III results expected Q1
6,102 subjects
Pfizer’s modRNA vaccineSeasonal influenzaPhase III results expected 2023
36,200 subjects
Roche's/BioNTech’s RO7198457Advanced melanomaPhase II results expected H1
131 subjects
BioNTech’s BNT-163Herpes lesionsPhase I results expected H2
108 subjects
GlobalData